Physician profile
Heath Gerig
NPI 1568096188
$712.75
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $713.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.32 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $110.42 | 2021 | |
| Novartis Pharmaceuticals Corporation | $77.80 | 2021 | |
| Lilly USA, LLC | $76.28 | 2021 | |
| Sanofi-Aventis U.S. LLC | $64.44 | 2021 | |
| Amgen INC. | $56.97 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $37.43 | 2021 | |
| Glaxosmithkline, LLC. | $33.29 | 2021 | |
| Astellas Pharma US INC | $24.57 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $24.00 | 2021 | |
| Novo Nordisk INC | $23.60 | 2021 | |
| Daiichi Sankyo INC. | $15.90 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.45 | 2021 | |
| Pfizer INC. | $12.28 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heath Gerig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.